These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9440547)

  • 1. Induction of autocytotoxic T cells with cyclosporine and interferon-gamma for patients with non-Hodgkin's lymphoma after transplantation of peripheral blood stem cells.
    Nakao S; Miura Y; Zeng W; Takami A; Sugimori N; Yamazaki H; Yachie A; Shiobara S; Matsuda T
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S65-9. PubMed ID: 9440547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of autologous graft-versus-host disease with cyclosporin A after peripheral blood stem cell transplantation: analysis of factors affecting induction.
    Miura Y; Ueda M; Zeng W; Wang H; Takami A; Yamazaki H; Kawamura Y; Shiobara S; Nakao S
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 2):S51-7. PubMed ID: 10887334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34(+) cells.
    Miura Y; Ueda M; Takami A; Shiobara S; Nakao S; Hess AD
    Bone Marrow Transplant; 2003 Oct; 32(8):785-90. PubMed ID: 14520422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.
    Bolaños-Meade J; Garrett-Mayer E; Luznik L; Anders V; Webb J; Fuchs EJ; Huff CA; Matsui W; Borrello IM; Brodsky R; Kasamon YL; Swinnen LJ; Flinn IW; Ambinder RF; Jones RJ; Hess AD; Vogelsang GB
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1185-91. PubMed ID: 17889355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
    Miura Y; Thoburn CJ; Bright EC; Hess AD
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.
    Carella AM; Cavaliere M; Lerma E; Ferrara R; Tedeschi L; Romanelli A; Vinci M; Pinotti G; Lambelet P; Loni C; Verdiani S; De Stefano F; Valbonesi M; Corsetti MT
    J Clin Oncol; 2000 Dec; 18(23):3918-24. PubMed ID: 11099321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong increase in the percentage of the CD8bright+ CD28- T-cells and delayed engraftment associated with cyclosporine-induced autologous GVHD.
    Garin L; Rigal D; Souillet G; Bernaud J; Mérieux Y; Philippe N
    Eur J Haematol; 1996 Mar; 56(3):119-23. PubMed ID: 8598229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
    Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
    J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythroderma after autologous bone marrow transplantation modified by administration of cyclosporine and interferon gamma for breast cancer.
    Horn TD; Altomonte V; Vogelsang G; Kennedy MJ
    J Am Acad Dermatol; 1996 Mar; 34(3):413-7. PubMed ID: 8609251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells.
    van der Wall E; Horn T; Bright E; Passos-Coehlo JL; Bond S; Clarke B; Altomonte V; McIntyre K; Vogelsang G; Noga SJ; Davis JM; Thomassen J; Ohly KV; Lee SM; Fetting J; Armstrong DK; Davidson NE; Hess AD; Kennedy MJ
    Br J Cancer; 2000 Dec; 83(11):1405-11. PubMed ID: 11076645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial.
    Vogelsang G; Bitton R; Piantadosi S; Altomonte V; Horn T; Jones R; Miller C; Marcellus D; Abrams R; Hess A
    Bone Marrow Transplant; 1999 Sep; 24(6):637-40. PubMed ID: 10490729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
    Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M
    Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon.
    Gryn J; Johnson E; Goldman N; Devereux L; Grana G; Hageboutros A; Fernandez E; Constantinou C; Harrer W; Viner E; Goldberg J
    Bone Marrow Transplant; 1997 Feb; 19(3):221-6. PubMed ID: 9028549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.
    Weisdorf D; Miller J; Verfaillie C; Burns L; Wagner J; Blazar B; Davies S; Miller W; Hannan P; Steinbuch M; Ramsay N; McGlave P
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):217-23. PubMed ID: 9360784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infusions of interleukin-1 alpha after autologous transplantation for Hodgkin's disease and non-Hodgkin's lymphoma induce effector cells with antilymphoma cytolytic activity.
    Katsanis E; Weisdorf DJ; Xu Z; Dancisak BB; Halet ML; Blazar BR
    J Clin Immunol; 1994 May; 14(3):205-11. PubMed ID: 7929695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstitution of the cellular immune response after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin's lymphoma.
    Nolte A; Buhmann R; Emmerich B; Schendel D; Hallek M
    Br J Haematol; 2000 Feb; 108(2):415-23. PubMed ID: 10691875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of autologous graft-versus-host disease after autologous peripheral blood stem cell transplantation.
    Nakamura H; Nakao T; Ujiie H; Karasuno T; Teshima H; Komatsu K; Ishiguro S; Hiraoka A; Masaoka T
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 2):S457-61. PubMed ID: 10329849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal timing for the collection and in vitro expansion of cytotoxic CD56(+) lymphocytes from patients undergoing autologous peripheral blood stem cell transplantation.
    Clausen J; Petzer AL; Vergeiner B; Enk M; Stauder R; Gastl G; Gunsilius E
    J Hematother Stem Cell Res; 2001 Aug; 10(4):513-21. PubMed ID: 11522234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic aspergillosis in a patient with non-Hodgkin's lymphoma developing acute graft-versus-host disease after autologous peripheral blood stem cell transplantation.
    Messina G; Quartarone E; Console G; Cuzzola M; Iacopino O; Martino M; Irrera G; Morabito F; Iacopino P
    Haematologica; 2002 Jul; 87(7):ECR22. PubMed ID: 12091138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine-induced autologous graft-versus-host disease following autologous blood stem cell transplantation for lymphoma.
    Pati AR; Godder KT; Abhyankar SH; Gee AP; Henslee-Downey PJ
    Bone Marrow Transplant; 1996 Jun; 17(6):1081-3. PubMed ID: 8807118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.